LAT attended BIO 2019 held in Philadelphia during May, this is one of the largest meet up centers for Biotech´s and Pharma Leaders, where one-on-one partnering is made. LAT was one of the most important Regional CRO´s to attend the BIO.

LAT is conducting a retrospective study in Chagas, analyzing medical charts for 4000 patients.

LAT is pleased to announce the initiation of a new Protocol in prevention of Hemolytic Uremic Syndrome. The initial Phase will include 160 subjects under 5 years old.

AZIDUS and LAT are pleased to announce their Strategic Alliance of mutual collaboration creating a stronger regional full-service CRO. This partnership enhances the access to industry leading therapeutic expertise, a regional approach while still maintaining focus on the local proximity, as well as the quality and customer service that is highly valued by our clients.

LAT ‘s Medical staff started providing support in new Initiatives in Chagas Disease.

LAT reached the target of 316 children enrolled with acute diarrhea in less than a year.